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Assessment of the Validity of Reported Antibiotic
Allergic Reactions in Pediatric Patients
Lauren E. Miller, Pharm.D., Chad A. Knoderer, Pharm.D., Elaine g. Cox, M.D., and
Martin B. Kleiman, M.D.
Study Objective. To determine whether a reported antibiotic allergy was
likely to have been immunologically mediated.
Design. Questionnaire-based study.
Setting. Tertiary care, freestanding children’s hospital.
Patients. One hundred patients aged 1 month–18 years for whom guardians reported an allergy to an
antibiotic at the time of hospital admission between October 2009 and March 2010.
Intervention. guardians of the patients were interviewed by using a standardized allergy assessment
questionnaire.
Measurements and Main Results. Based on answers to the questionnaire, the reported allergic reactions
were categorized to determine if they were true allergies or adverse reactions. Among the 100 patients,
reported allergies were categorized as immunologically mediated reactions in 58%, non–immunologically
mediated adverse drug reactions in 27%, no reaction in 3%, and unknown in 12%. Reactions to
penicillins, cephalosporins, or sulfonamides were reported most frequently and were attributed to
immunologically mediated reactions in 68% (26/38), 74% (17/23), and 67% (10/15) of instances,
respectively.
Conclusion. Use of the allergy assessment questionnaire determined that 58% of the 100 reported
antibiotic allergies fulfilled criteria for an immunologically mediated reaction. These findings underscore
the utility of an allergy assessment questionnaire, versus a simple drug history, in improving the accuracy
of reported antibiotic reactions.

Allergic reactions are thought to be responsible for 6–10% of adverse reactions to drugs and can
be acute, serious, or life-threatening.1 Drug reactions are considered allergic if they are
immunologically mediated, as defined by the gell and Coombs classification (Table 1).1
Allergies to penicillin account for 5–20% of the reported drug reactions.2, 3 Approximately 10–
30% of patient-reported antibiotic allergies have been found not to be immunologically
mediated.2–8 We are aware of no studies that have addressed the validity of reported drug
reactions in children, and none that have used a questionnaire to assess the validity of reported
reactions.2–8
Although parents or guardians often recall being informed by a health care professional that their
child has an antibiotic allergy, many cannot accurately describe the details of these drug
reactions. In these settings, parents and health care professionals are often reticent to administer
the antibiotic or agents in the same drug class. In most instances, caregivers are unable to
distinguish non–immunologically mediated adverse drug reactions from those likely to be
allergic reactions. Thereafter, when queried by health care providers, such intolerances may be
recorded as drug allergies. Both overreporting and documentation within the medical record

often result in use of alternative agents with wider antimicrobial spectra, narrower safety
profiles, and/or higher costs.
The objective of this study was to determine whether a reported antibiotic allergy was likely to
have been immunologically mediated by using an allergy assessment questionnaire.
Table 1 Gell and Coombs Classification of Allergic Reactions1
Type
I

Reaction Name
Anaphylactic
(IgE mediated)

II

Cytotoxic

III

Immune
complexes

IV

Cell mediated

Description
Allergen binds to IgE on basophils or mast cells and causes
inflammatory
mediators. This results in anaphylaxis, edema, and
bronchospasm.
Anaphylaxis can involve a single organ or multiple organs,
including
the respiratory tract, nasal mucosa, skin, or gastrointestinal tract.
Reaction involves destruction of host cells, usually blood cells,
through
cell-associated antigens that initiate cytolysis by antigen-specific
antibodies.
This can result in hemolytic anemia, agranulocytosis, or
thrombocytopenia.
Antigen-antibody complexes form and deposit on blood vessel
walls.
This activates complement and causes localized edematous or
erythematous
reactions or serum sickness.
Antigens activate lymphocytes, which release inflammatory
mediators, leading
to dermatologic manifestations involving erythema and
indurations.

Time to Onset
Rapid
(within 30 min)

5–12 hrs

3–8 hrs

24–48 hrs

IgE = immunoglobulin E.

Methods
Study Population and Setting
This study was conducted after receiving approval from the institutional review board of Indiana
University–Purdue University, Indianapolis, Indiana. Eligible patients were those aged 1 month–
18 years who, on admission to a tertiary pediatric hospital, were reported by a parent or guardian
to have previously experienced an allergic reaction to an antibiotic. Exclusion criteria were
patients in the neonatal intensive care unit, those who were readmitted after initial study
inclusion, and patients whose medical records described adverse reactions that were unlikely to
have been immunologically mediated (i.e., vancomycin with a listed reaction of red man’s
syndrome or macrolide antibiotics in patients receiving cyclosporine or tacrolimus) as
determined by study investigators.
One hundred patients were selected by using a randomly generated list of hospital room numbers
from among those reporting a history of an antibiotic allergy when being admitted from October
2009 through March 2010. All patients’ guardians were interviewed by one pharmacist using a
standardized allergy assessment questionnaire (Appendix 1), which was derived from a
compilation of recommendations for obtaining an accurate allergy history.2, 4–8

Drug reactions were categorized as either a true allergy or an adverse reaction. Drug reactions
that were likely to have been immunologically mediated were considered true allergies as
defined by the assessment questionnaire. An adverse reaction was presumed probable if either all
reported symptoms were included within the adverse reaction column of the assessment
questionnaire, or an antibiotic in the same class (penicillin or cephalosporin) had subsequently
been administered without the development of an allergic reaction. For example, if a patient had
a reported allergy to penicillin, but had subsequently received amoxicillin without a reaction, the
reaction to penicillin would be considered an adverse reaction. Adverse reactions that were
considered non–immunologically mediated included vomiting and/or diarrhea, behavioral
changes, muscle cramps, or urinary tract symptoms.
Drug reactions were considered “unknown” if not directly observed by the guardian or if the
interval between the reaction and antibiotic administration was unclear. “No reaction” was
recorded if the patient had never received the drug or was receiving the drug at the time of the
interview and no reaction occurred.
Guardians were also queried as to whether the allergic reaction had been“confirmed.” This was
defined if the guardian recalled being told by a physician or other health care provider that the
patient was allergic to the drug. Skin or other challenge tests were not performed.
Statistical Analysis
Descriptive statistics were used for patient demographics, the percentage of reported antibiotic
allergies that were assessed to have been true allergies, and the occurrence of true allergies
among the antibiotic classes. Statistical analysis was conducted with the Statistical Package for
Social Sciences, version 16.0 (SPSS, Inc., Chicago, IL) and Excel 2007 (Microsoft Corp.,
Redmond, WA).
Results
Patient demographics are summarized in Table 2. guardian-reported reactions in the 100 patients
were categorized as true allergy in 58%, adverse reaction in 27%, no reaction in 3%, and
unknown in 12%. The reactions were categorized as unknown based on the following criteria: no
recollection of the signs or symptoms (five patients); receipt of multiple antibiotics when the
reaction occurred (three patients); patient was readmitted to the hospital after undergoing
treatment, and it was unclear whether symptoms resulted from an allergic reaction or were
attributable to the primary illness (one patient); guardian did not recall the events leading to the
history of allergy (one patient); guardian told by primary physician that reaction should be listed
as allergy (one patient); and guardian recalled being told that the patient had an allergic reaction,
but guardian did not recall the name of the drug (one patient). Medical record–documented drug
allergies were most commonly attributed to the penicillin class, cephalosporins, and/or
sulfonamides (Table 3); these reactions were categorized as immunologically mediated in 68%,
74%, and 67%, respectively.

Table 2 Demographics of the Study Children
Characteristic
Age on admission, yrs (n=100)
Age when allergic reaction occurred,
yrs (n=87)

Value
Mean •± SD
8.77 ± 4.76
4.48 ± 3.82
Percentage of
Patients
(n=100)

Age group
1 mo–5 yrs
6–11 yrs
12–17 yrs
Male
Interviewee
Mother
Father
Both parents
Other guardian
Medical record–documented
antibiotic
Specific drug
Drug class
Specific reaction documented in
medical
record

27
37
36
57
81
13
1
5
91
9
33

A reaction was recalled by 87 of the 100 guardians interviewed. Among the 87 reported
reactions, 40 (46%) were hives or blistering and 39 (45%) were rashes (Table 3). Sixteen patients
(18%) were reported to have had both reactions. The interval between drug administration and
reaction onset was known in 33 (83%) of the 40 hives or blistering reactions and 31 (79%) of the
39 instances of rash. Of these 33 hives or blistering reactions, 19 (58%) occurred with the first
dose and 14 (42%) occurred later in therapy. Of these 31 instances of rash, 12 (39%) occurred
after the first dose, 17 (55%) occurred later in treatment, and 2 (6%) occurred after treatment.
Rash was most commonly reported with penicillin antibiotics (18/39 [46%]), followed by
sulfonamides (8/39 [21%]), and cephalosporins (7/39 [18%]). guardians reported that the
reaction was confirmed as a true immunologically mediated reaction in 67 (77%) of the 87
instances, with 36% resulting from a physician visit, 12% over the phone, 16% in an emergency
room visit or at another hospital, and 13% at the study hospital. There were no reports of skin
testing.
Discussion
Pharmacists and physicians often rely on the guardian’s recollection within the medical record
documentation to assess the validity of reported allergies to drugs. The terms “rash” and “hives”
are often defined differently by guardians and health care professionals. The results of such
inquiries into reported allergies must be objectively interpreted since many are found not to be
immunologically mediated. Revalidation of these reports should be conducted at each encounter.

Inaccurate classification of adverse drug reactions as immunologically mediated reactions has
been shown to result in substitution of agents with wider spectra of activity, narrower safety
profiles, and higher costs.3, 8 Such reports have been shown to alter antibiotic selection in 30%
of patients.8 Cross-sensitivity to cephalosporins in patients allergic to penicillin has been
reported in as few as 0.5% of patients.9 However, many believe that the range of crosssensitivity to cephalosporins is higher (8–18%) among patients with penicillin allergy, resulting
in limitation of use of penicillins, cephalosporins, and potentially carbapenems from an antibiotic
regimen.9
A study performed in an adult acute-care teaching hospital found that 28% of allergy labels
could be removed after analyzing the results of a drug allergy assessment.4 Similar studies have
concluded that patient-reported drug allergies were found to be valid in 22–50% of instances.2,
4, 5 Similar to our findings, another group of authors determined that β-lactam antibiotics and
sulfonamides accounted for 63% of patient- reported allergies, but, in 9% of cases, the patients
were found either to be nonallergic or to have not received the drug.6
Our assessment questionnaire examined guardian-recalled historical information in a consistent
fashion, which was used to assess the probability of a patient having an immunologically
mediated drug reaction. Both for the purpose of our analysis and in an effort to simplify our
questionnaire, a detailed description of rashes was not used, rather the presence or absence of
cutaneous reactions was noted. Since viral exanthems are common causes of fever in children, it
is difficult to differentiate rashes caused by infection and drug allergy.3 One group of authors
reported penicillin-associated rashes in 7% of treated children; however, those considered
immunologically mediated occurred in only about 3% of treated children.10 The percentage of
immunologically mediated drug reactions found in our study (58%) may have been
overestimated, since rashes due to the primary disease process could have been attributed to true
allergies.
Guardians reported that being told by aphysician or other health care provider that their child had a drug
allergy and/or having a physician prescribe an alternative antibiotic was interpreted as validation of a drug
allergy. A study that used skin testing and oral antibiotic challenge to confirm immunologically mediated
antibiotic reaction found that only 34% of immunologically mediated reactions to penicillins and
cephalosporins can be accurately predicted by the appearance of the rash at the time of the presumed
reaction.11 guardians reported that in 12% of instances, confirmation or validation of allergic reactions was
based solely on telephone conversations with a care provider. In these instances, guardians should be
informed that further evaluation, with use of skin testing or oral challenge, may more accurately assess
the validity of the reaction.

Table 3 Characterization of Antibiotic Reaction
Variable

Medical record–
documented drug
allergy
Penicillins
Cephalosporins
Sulfonamides
Macrolides
Vancomycin
Clindamycin
Fluoroquinolone
Metronidazole
Guardian-described
Reaction3
Hives or blistering
Diffuse rash
Otherb
Unknown
Nausea or vomiting
Severe itching
Diarrhea
Shortness of breath
Anaphylaxis
Serum sickness
Drowsiness
Headache
Irritability
Muscle cramps
Time to reaction onset
First dose
During therapy
After completion
of therapy
Unknown
Antibiotic
rechallenged
Yes
No
Unknown

Repeat reaction
during rechallenge
Yes
No
Unknown
aMultiple

bIncluded

Percentage of
Patients with
Reaction
(n=100)

No. (%) of
Reactions
Categorized as
Immunologically
Mediated

40
25
18
9
4
2
1
1
(n=87)

26 (68)
17 (74)
10 (67)
2 (25)
1 (33)
1 (100)
0 (0)
1 (100)

46
45
29
15
10
10
8
8
3
3
2
<1
<1
<1
(n=100)
33
35
2
30

17
75
8
No. (%) of 17
Rechallenges

14 (82)
2 (12)
1 (6)

reaction symptoms were reported by some guardians.

elevated transaminase levels, red man’s syndrome, diaper rash, intestinal bleeding,
flushing, redness at the injection site, swelling, erythema multiforme, raw and painful skin, facial
rash, and seizure.

Limitations
A potential limitation of this study could have been a guardian’s inaccurate recollection and/or description
of the rash, as well as the recollection of the temporal sequence of events. A previously published
assessment of the validity of antibiotic allergies found that 98% of patients recalled the name of the drug
and the nature of the allergic reaction.8 In our study, 87% of the 100 guardians could describe the child’s
reaction. The reports of “false-positive” allergies to antibiotics other than penicillins, cephalosporins, and
sulfonamides appear high, but the percentage of those reports was low at 17%. This may be attributed to
the imprecise documentation in the medical record leading to the false-positive allergy. In addition, 12%
of 100 reactions were categorized as unknown because limited information was available (i.e., the
guardian did not recall specific details) to determine if the reactions were likely to be immunologically
mediated.
Conclusion
An allergy assessment questionnaire found that 58% of 100 reported antibiotic allergies fulfilled criteria
for an immunologically mediated reaction. There are opportunities to improve the assessment and
documentation of reported antibiotic allergies in pediatric patients. Use of an allergy assessment
questionnaire may reveal discrepancies necessitating further evaluation, which may impact antibiotic
utilization.
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